Oct 19, 2020 04:05PM
Sep 18, 2020 04:05PM
Sep 14, 2020 12:28AM
Sep 10, 2020 08:00AM
Sep 8, 2020 08:00AM
Aug 6, 2020 07:00AM
Aug 4, 2020 08:00AM Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
Jul 30, 2020 04:01PM
Jul 17, 2020 04:01PM
Jun 11, 2020 12:09PM
Jun 10, 2020 08:00AM
May 27, 2020 07:51AM
May 26, 2020 08:02AM
May 26, 2020 08:00AM Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease
May 7, 2020 07:00AM
May 4, 2020 08:01AM
May 4, 2020 08:00AM
Feb 12, 2020 07:00AM
Jan 15, 2020 08:00AM
Nov 7, 2019 07:00AM
Aug 8, 2019 05:18PM Kala Pharmaceuticals (KALA) Receives FDA CRL for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial
Aug 8, 2019 04:01PM
Aug 6, 2019 07:00AM
Jul 30, 2019 04:05PM
Jun 20, 2019 04:05PM
May 30, 2019 08:00AM
May 17, 2019 04:05PM
May 9, 2019 07:25AM Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat
May 9, 2019 07:00AM
May 7, 2019 08:00AM
May 2, 2019 08:00AM
Apr 18, 2019 04:05PM
Apr 1, 2019 08:00AM
Mar 11, 2019 04:02PM
Mar 11, 2019 04:01PM Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 6, 2019 08:00AM
Mar 4, 2019 08:00AM
Feb 22, 2019 04:05PM
Jan 18, 2019 04:05PM
Jan 7, 2019 07:00AM
Jan 2, 2019 08:00AM
Dec 26, 2018 07:01AM Kala Pharmaceuticals (KALA) Announces NDA for KPI-121 0.25% for Dry Eye Disease Has Been Accepted for Review by FDA
Dec 26, 2018 07:00AM
Aug 9, 2018 07:00AM
Aug 8, 2018 04:05PM
Jul 31, 2018 08:19AM
Jul 31, 2018 08:00AM
Jul 23, 2018 07:23AM
Jun 19, 2018 04:02PM Kala Pharmaceuticals (KALA) Provides Update to KPI-121 0.25% Development Plan, Sees NDA in H2
Jun 19, 2018 04:01PM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All